A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy
Longer-term PRADA trial results weigh in for low-risk group
Longer-term PRADA trial results weigh in for low-risk group
Death rate vs urban areas continues to widen for cancer, heart disease, lung disease, and stroke
Adoption approached 60% as recently as 2022
Long COVID functional manifestations differ from post-vaccine effects
In a study encompassing more than 80,000 patient-years, people with psoriasis taking IL-23 inhibitors saw the lowest risk of paradoxical atopic dermatitis (AD) compared with…
Death rate vs urban areas continues to widen for cancer, heart disease, lung disease, and stroke
Immunotherapy (IO) and combination therapy have substantially extended survival for patients with metastatic renal cell carcinoma (mRCC), but these therapies have also increased the financial…
Japanese researchers open new front in SLE therapy
Clonal hematopoiesis a red flag for people with asymptomatic carotid atherosclerosis
An increased number of antibiotic courses corresponded to a dose-response-like increased risk
Gun violence in hospitals is rising — we need a bold new safety approach